NeurologyLive® Friday 5 — August 28, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more or watch now buttons for more details and information about each highlight.

1: Factor XIa Inhibition as a Potential New Frontier in Secondary Stroke Prevention: Seemant Chaturvedi, MD

In a recent interview, Seemant Chaturvedi, MD, the Stewart J. Greenebaum Endowed Professor in Stroke Neurology at University of Maryland School of Medicine, discussed the unmet needs in secondary stroke prevention. [WATCH TIME: 5 minutes]

2: The Overlooked Burden of Bulbar Symptoms in Spinal Muscular Atrophy

In a recent Q&A interview, Dustin Gable, MD, PhD, a pediatric neuromuscular neurologist at Johns Hopkins Medicine, discussed why bulbar dysfunction remains an underrecognized burden among patients with spinal muscular atrophy.

3: Mentorship, Career Development, and the Future of Brain Injury Medicine

In a recent Q&A interview, Erika Trovato, DO, MS, program director of the Brain Injury Medicine Fellowship at Burke Rehabilitation Hospital, provided clinical advice for trainees and early-career physicians looking to establish themselves in the field.

4: Early Diagnosis, Multidisciplinary Care Redefine the SMA Treatment Journey

In a recent Q&A interview, Nestor Galvez-Jimenez, MD, a neurologist at Baptist Health Miami Neuroscience Institute, discussed how advancements have changed the landscape of care for patients living with spinal muscular atrophy.

5: How the Field Built the First Consensus Clinical Trial Framework for Charcot-Marie-Tooth Disease

In a recent Q&A interview, Brian Lin, PhD, Research Director at the Muscular Dystrophy Association, commented on the first-ever clinical trial framework for Charcot-Marie-Tooth disease and where the field's biomarker evidence still needs to grow.

Don’t have time to read or watch a full video interview? Click here to check out our shorts!